Molina Healthcare Shares Fall Sharply as One Major Fund Invests Millions
Long Beach, Sunday, 22 March 2026.
Molina Healthcare’s stock plummeted 53 percent this month, yet one major fund took advantage of the lower price by investing $8.5 million, highlighting a fascinating divide in market expectations.
The Catalyst Behind the Collapse
On March 20, 2026, Molina Healthcare (NYSE: MOH) closed at $140.02, reflecting a marginal daily decline of $2.19 [1]. The managed care company, headquartered in Long Beach, California [4], has found itself at the center of a sector-wide storm. On March 14, 2026, a so-called “Medicare shock” wiped out nearly $100 billion in market value across health insurers following an underwhelming proposal for 2027 Medicare Advantage payments [3]. This regulatory headwind severely impacted Molina, pushing its stock closer to its 52-week low of $121.06, a staggering fall from its 52-week high of $359.97 [3]. At its recent close, the equity was trading at a deficit of -61.102 percent from its peak [1][3].
Earnings Pressures and Analyst Downgrades
The recent market turbulence compounds underlying fundamental challenges for the insurer. While financial platforms report Molina’s 2025 revenue at $43.56 billion—an increase of 11.23 percent from the previous year’s $39.16 billion [4]—the company’s fourth-quarter 2025 earnings release indicated annual revenue exceeding $45.43 billion [2]. Despite this top-line growth, profitability has contracted sharply due to rising medical costs and challenging contract terms [2]. Net income for 2025 plummeted to $472 million [2][4], representing a stark decline of -59.97 percent [4]. Consequently, Molina’s earnings per share (EPS) for the current year is down -54.29 percent [3].
Contrarian Bets and Long-Term Projections
Amid the prevailing pessimism, some institutional investors are identifying a potential floor in Molina’s valuation. Redwood Capital Management recently purchased 51,600 shares of the company, an investment estimated at $8.48 million [2]. This accumulation suggests a belief that the market has overreacted to near-term margin pressures. The optimism may be anchored in the company’s long-term forecasts, which project revenue reaching $50.7 billion and earnings climbing to $1.3 billion by 2028 [2]. Achieving this would require an annual revenue growth rate of 6.8 percent and an earnings recovery of $0.2 billion from a baseline of $1.1 billion [2].